With health reform and the shift to accountable, evidence-based medicine slowly but surely transforming the nation’s massive but troubled healthcare system, new moves are afoot in both the legislative and executive branches of government that will further elevate the role played by the nation’s 300,000 pharmacists.
Pharmacies and clinics on wheels? That’s the premise behind the growing effort by retail pharmacy and clinic providers to expand their reach via specially equipped buses and other vehicles that provide on-the-spot, temporary access to needed health services in hundreds of communities nationwide.
While the big four analgesic manufacturers — Bayer, Pfizer, McNeil and Novartis — command the lion’s share of retail ad support behind their mega analgesic brands, Prestige Brands and BedRock Brands are making headway promoting their niche pain relieving products.
There was a $1.1 billion gain in OTC sales between 2013 and 2014, according to data culled from IRI, some $500 million of which can be attributed to an increase in sales across all cough-cold/allergy/sinus products and an approximate $300 million to a rise in digestive sales.